CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,650 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01142674
NCT01142674N/ACompleted

Prospective Collection of Data in Pts With Peripheral T-Cell Lymphoma: PTCL,NOS;AITL; Extranodal NK/T-cell;Enteropathy-type; Hepatosplenic γ-δ; Subcutaneous Panniculitis-like; ALCL,Primary Systemic Type. By the Intl. T-Cell Lymphoma Project

Associazione Angela Serra per la ricerca sul cancro·observational·Posted Jun 11, 2010·Updated Jul 8, 2019

In Brief

An observational study for Lymphoma, T-Cell, Peripheral. Completed, enrolled 1,650 participants across 76 sites in 14 countries.

Detailed Summary

The designed study follows up the retrospective previous one by the International T-cell Non-Hodgkin's Lymphoma Study Group (International Peripheral T-Cell Lymphoma Project). It is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed patients with the more frequent subtypes of Peripheral T-cell lymphoma (Peripheral T-cell lymphoma unspecified and Angioimmunoblastic T-cell lymphoma) and to better define clinical characteristics and outcome of the more uncommon subtypes

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina, Brazil, Chile, China, France, Israel, Italy, Slovakia, South Korea, Spain, Switzerland, United Kingdom, United States, Uruguay

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 11, 2010
Enrollment StartSep 1, 2006
Primary CompletionJul 1, 2016
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 9.8 yearsPosted 16.1 years ago